Locations

St. Louis, MO, USA · San Diego, CA, USA · Missouri City, MO, USA

industry

Biotechnology · Therapeutics

Size

11 - 50 employees

Stage

Series C

founded in

2018

Wugen is developing off-the-shelf cellular therapies for cancer. Our NK cell therapy products originate from healthy donors and are further manipulated in order to enhance their function to eliminate cancer cells. Our NK cell and CAR-T immuno-oncology therapies address the needs of patients with solid tumors, acute myeloid leukemia (AML), and T-cell malignancies.

Something looks off?
Open jobs at Wugen

On-site & Remote